Baxter Corporation; leaks of intravenous bags
Summary
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot number |
|---|---|---|---|---|---|
BAXTER CORPORATION |
0.9% SODIUM CHLORIDE INJECTION, USP |
DIN 00060208 |
Solution |
SODIUM CHLORIDE 900mg / 100mL |
W1I14B0F, W1I15B0, W1I23B0, W1I24B0, W1I30B0, W1J07B0, W1J20B0, W1J22B0, W1J25B1, W1J26B0, W1J27B1, W1J29B0, W1K02B0, W1K03B0, W1K19B0, W1K25B0, W1K25B0F, W1L02B0, W1L03B0, W1L09B0, W1L10B0, W1L10B0B, W1L11B0, W1L16B0, W1L17B0, W2A13B0, W2A14B0, W2A19B1, W2A20B0, W2A21B0, W2A22B0, W2A26B0, W2A29B0, W1H13B0, W1H19B0, W1H20B0, W1H26B0, W1H27B0, W1I01B0, W1I03B0, W1I09B0, W1I10B0, W1I14B0 |
BAXTER CORPORATION |
LACTATED RINGER'S INJECTION, USP |
DIN 00061085 |
Solution |
CALCIUM CHLORIDE 20mg / 100mL; POTASSIUM CHLORIDE 30mg / 100mL; SODIUM CHLORIDE 600mg / 100 mL; SODIUM LACTATE 310mg / 100mL |
W1H04B0, W1I17B0, W1J28B0, W1K26B0, W1L22B0, W2A27B0, W2A27B0S |
Issue
Intravenous bag may be leaking in affected lots.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Related recalls and alerts
Additional information
Background
Depth of recall: End Users
Details
Baxter Corporation
7125 Mississauga Road
Mississauga ON
L5N 0C2
Get notified
Receive notifications for new and updated recalls and alerts by category.